Tag Archives: PDCO

Top Low Price Stocks To Buy Right Now

Protect American jobs by getting tough on China.

That’s the underlying idea behind President-elect Donald Trump’s threat of a 45% tariff against China as a ploy to bring jobs back to America.

Before pursuing that strategy, however, Trump might want to check out what happened when his predecessor tried that.

President Obama slapped a stiff 35% tariff on Chinese tires in 2009 after American companies complained about unfair competition. They said China was flooding America with tires at low prices making it tough for U.S. companies to compete. The tire tariff gradually waned, and finally ended in 2012.

The tariff saved 1,200 U.S. tire jobs, which had been in sharp decline. And U.S. tire production rose after a major decline.

“Over a thousand Americans are working today because we stopped a surge in Chinese tires,” Obama said in his 2012 State of the Union address.

But a study from the Peterson Institute of International Economics found that the tariffs cost Americans in many other ways.

Top Low Price Stocks To Buy Right Now: Patterson Companies, Inc.(PDCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    American International Group Inc. grew its holdings in shares of Patterson Companies (NASDAQ:PDCO) by 320.9% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 182,605 shares of the company’s stock after purchasing an additional 139,218 shares during the period. American International Group Inc. owned approximately 0.19% of Patterson Companies worth $4,059,000 as of its most recent SEC filing.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Patterson Companies (PDCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Patterson Companies (NASDAQ:PDCO) had its price objective decreased by Morgan Stanley from $21.00 to $19.00 in a report released on Friday. Morgan Stanley currently has an underweight rating on the stock.

  • [By Joseph Griffin]

    Patterson Companies, Inc. (NASDAQ:PDCO) announced a quarterly dividend on Wednesday, September 19th, RTT News reports. Shareholders of record on Friday, October 12th will be given a dividend of 0.26 per share on Friday, October 26th. This represents a $1.04 dividend on an annualized basis and a yield of 4.40%. The ex-dividend date is Thursday, October 11th.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Patterson Companies (PDCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Low Price Stocks To Buy Right Now: Balchem Corporation(BCPC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Balchem (NASDAQ: BCPC) is one of 25 public companies in the “Chemicals & allied products” industry, but how does it contrast to its rivals? We will compare Balchem to similar businesses based on the strength of its analyst recommendations, earnings, valuation, dividends, profitability, institutional ownership and risk.

  • [By Max Byerly]

    Carillon Tower Advisers Inc. boosted its stake in Balchem Co. (NASDAQ:BCPC) by 656.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,180 shares of the basic materials company’s stock after purchasing an additional 47,884 shares during the period. Carillon Tower Advisers Inc. owned about 0.17% of Balchem worth $4,510,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    JPMorgan Chase & Co. boosted its position in shares of Balchem Co. (NASDAQ:BCPC) by 20.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 73,196 shares of the basic materials company’s stock after buying an additional 12,487 shares during the period. JPMorgan Chase & Co.’s holdings in Balchem were worth $5,985,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Balchem Co. (NASDAQ:BCPC) – Equities research analysts at Seaport Global Securities lifted their Q2 2019 EPS estimates for shares of Balchem in a report issued on Thursday, February 28th. Seaport Global Securities analyst B. Hundley now forecasts that the basic materials company will post earnings per share of $0.81 for the quarter, up from their prior forecast of $0.80. Seaport Global Securities currently has a “Neutral” rating on the stock. Seaport Global Securities also issued estimates for Balchem’s Q3 2019 earnings at $0.78 EPS, Q4 2019 earnings at $0.83 EPS, FY2019 earnings at $3.15 EPS and FY2020 earnings at $3.30 EPS.

  • [By Travis Hoium]

    Balchem’s (NASDAQ:BCPC) fourth-quarter 2018 results, reported this week, showed continued solid revenue and earnings growth. Notably, the specialty-ingredients supplier achieved growth this year without the benefit of large acquisitions, which have helped results in the past. 

Top Low Price Stocks To Buy Right Now: Monroe Capital Corporation(MRCC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Monroe Capital (NASDAQ:MRCC) had its price target reduced by National Securities from $17.00 to $16.00 in a research note issued to investors on Monday. National Securities currently has a buy rating on the financial services provider’s stock.

  • [By Logan Wallace]

    PJT Partners (NASDAQ: MRCC) and Monroe Capital (NASDAQ:MRCC) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.

  • [By Ethan Ryder]

    Monroe Capital (NASDAQ:MRCC) was downgraded by research analysts at BidaskClub from a “strong-buy” rating to a “buy” rating in a note issued to investors on Friday.

  • [By Motley Fool Transcribers]

    Monroe Capital Corp  (NASDAQ:MRCC)Q4 2018 Earnings Conference CallMarch 06, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Low Price Stocks To Buy Right Now: Natera, Inc.(NTRA)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Natera Inc (NASDAQ:NTRA) traded up 1% during mid-day trading on Monday after Morgan Stanley raised their price target on the stock from $21.00 to $41.00. Morgan Stanley currently has an overweight rating on the stock. Natera traded as high as $24.34 and last traded at $24.17. 12,757 shares were traded during trading, a decline of 99% from the average session volume of 958,145 shares. The stock had previously closed at $23.94.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Natera (NTRA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Daniel Sparks]

    Today’s after-hours headlines include food and beverage giant Kraft Heinz (NASDAQ:KHC) and healthcare diagnostics and research company Natera (NASDAQ:NTRA).

  • [By Logan Wallace]

    Natera (NASDAQ:NTRA) was downgraded by investment analysts at ValuEngine from a “buy” rating to a “hold” rating in a report issued on Monday.

  • [By Max Byerly]

    Natera Inc (NASDAQ:NTRA) shares traded down 10.7% during mid-day trading on Thursday after an insider sold shares in the company. The company traded as low as $21.99 and last traded at $22.14. 1,094,600 shares changed hands during mid-day trading, an increase of 173% from the average session volume of 400,551 shares. The stock had previously closed at $24.78.

Hot Financial Stocks To Own Right Now

LISTEN TO ARTICLE 1:54 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Exxon Mobil Corp. is refusing to turn over documents crucial to New York’s investigation into whether the oil giant’s public statements about climate change misled investors, the state’s top lawyer said.

Exxon hasn’t complied with subpoenas for cash-flow projections reflecting how it used so-called proxy costs to calculate the financial impact on its assets from future regulations tied to climate change, Attorney General Barbara Underwood said in a filing Tuesday in state court in Manhattan.

Hot Financial Stocks To Own Right Now: Patterson Companies, Inc.(PDCO)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Patterson Companies (NASDAQ:PDCO) Q4 2018 Earnings Conference CallJun. 21, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Gabelli Funds LLC lifted its stake in Patterson Companies (NASDAQ:PDCO) by 18.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 560,300 shares of the company’s stock after purchasing an additional 87,800 shares during the quarter. Gabelli Funds LLC owned 0.59% of Patterson Companies worth $12,455,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Joseph Griffin]

    Element Capital Management LLC acquired a new stake in Patterson Companies, Inc. (NASDAQ:PDCO) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 51,030 shares of the company’s stock, valued at approximately $1,134,000. Element Capital Management LLC owned about 0.05% of Patterson Companies as of its most recent filing with the SEC.

  • [By Brian Orelli]

    Shares of Patterson Companies (NASDAQ:PDCO) are up 4.4% at 12:45 p.m. EDT, having been up as much as 12.1%, after the dental and animal health company announcedresults of its fourth fiscal quarter that ended on April 28.

Hot Financial Stocks To Own Right Now: Pinnacle West Capital Corporation(PNW)

Advisors’ Opinion:

  • [By Joseph Griffin]

    M&T Bank Corp raised its position in Pinnacle West Capital Co. (NYSE:PNW) by 15.8% during the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 8,775 shares of the utilities provider’s stock after purchasing an additional 1,196 shares during the period. M&T Bank Corp’s holdings in Pinnacle West Capital were worth $700,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Pinnacle West Capital (PNW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Atria Investments LLC cut its stake in shares of Pinnacle West Capital Co. (NYSE:PNW) by 49.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,651 shares of the utilities provider’s stock after selling 4,560 shares during the period. Atria Investments LLC’s holdings in Pinnacle West Capital were worth $371,000 as of its most recent filing with the SEC.

Hot Financial Stocks To Own Right Now: Nabriva Therapeutics AG(NBRV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Ethan Ryder]

    Nabriva Therapeutics (NASDAQ:NBRV) last issued its earnings results on Tuesday, May 8th. The biotechnology company reported ($0.36) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.59) by $0.23. Nabriva Therapeutics had a negative return on equity of 79.30% and a negative net margin of 600.34%. The firm had revenue of $7.55 million for the quarter, compared to analyst estimates of $1.27 million. equities analysts anticipate that Nabriva Therapeutics will post -1.9 EPS for the current fiscal year.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Nabriva Therapeutics (NBRV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    After the company announced top-line data from an important phase 3 trial, shares of Nabriva Therapeutics(NASDAQ:NBRV), a clinical-stage biotech focused on next-generation antibiotics, fell as much as 14% in morning trading on Monday. As of 11:20 a.m. EDT, the stock was down 9%.

  • [By Lisa Levin]

    Shares of Nabriva Therapeutics plc (NASDAQ: NBRV) were down 14 percent to $4.6666 despite positive topline results from Phase 3 Lefamulin trial.

    Carver Bancorp, Inc. (NASDAQ: CARV) was down, falling around 21 percent to $6.59 after surging 201.37 percent on Thursday.